Novartis

FDA approves the use of Entresto

Medicine & Technology Jul 08, 2015

The U.S. Food and Drug Administration (FDA) already approved the use of the latest heart failure drug from Novartis. The drug, known as Entresto, was found to be potent in reducing death and hospitalizations related to cardiovascular diseases.

Novartis Seeking Approval for Medication to Treat 'Smoker's Cough'

Jan 09, 2015

Novartis AG, a Swiss drug maker, is seeking U.S. regulatory approval for two new drugs designed to treat chronic obstructive pulmonary disease (COPD), otherwise known as "smoker's cough". Approval of the drugs could generate an additional $1.4 billion for the company, while helping chronic smokers breathe a little clearer in the process.

Novartis

FDA approves the use of Entresto

Novartis Seeking Approval for Medication to Treat 'Smoker's Cough'

Most Popular

H5N1 Bird Flu Has Spread to Humans With 'Extraordinarily High' Mortality Rate, WHO Warns

Roman Lead Coffin Found To Hold Previously Unknown Human Child Remains in Fascinating Discovery

Pluto's Heart: Massive Ancient Collision May Explain How Dwarf Planet's Unique Heart-Shaped Feature Formed, Scientists Discover

Indestructible Tardigrades Survive Radiation by Ramping Up Production of DNA Repair Genes

Why Do People Struggle to Remember Mundane Things Like Passwords, Locking the Front Door?

Recommended Stories

Cheap Satellites Like SpaceX’s Starlink Could Disrupt Earth’s Magnetosphere and Expose Us to Deadly Cosmic Rays, Ex-NASA Physicist Warns

Tachyon Domination: Researchers Suggest the Universe May Be Full of Invisible Particles That Break Causality and Travel Faster Than Light

Sat-Nav in Space: Best Route Between Two Worlds Calculated Using 'Knot Theory' [Study]

When's the Best Time to Watch the Lyrids Meteor Shower That Will Peak This Weekend?